Interactive Financial Charts Not Available

Doximity (DOCS) | Financial Analysis & Statements

Doximity Inc. | Large-cap | Healthcare

$65.13

2.50%

Doximity vs Veeva Systems Doximity vs Ge Healthcare Doximity vs Tempus AI Doximity vs HealthEquity Doximity vs Waystar Holding Doximity vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 145.9M

Gross Profit 130.1M 89.18%

Operating Income 54.5M 37.36%

Net Income 53.3M 36.54%

EPS (Diluted) $0.27

Balance Sheet Metrics

Total Assets 1.3B

Total Liabilities 181.7M

Shareholders Equity 1.1B

Debt to Equity 0.17

Cash Flow Metrics

Operating Cash Flow 119.9M

Free Cash Flow 97.0M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Doximity Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue i	570.4M	475.4M	419.1M	343.5M	206.9M
Cost of Goods Sold i	55.9M	50.7M	53.5M	39.8M	31.2M
Gross Profit i	514.5M	424.8M	365.6M	303.8M	175.7M
Gross Margin % i	90.2%	89.3%	87.2%	88.4%	84.9%
Operating Expenses
Research & Development i	93.0M	82.0M	80.2M	62.4M	43.9M
Selling, General & Administrative i	191.4M	171.0M	160.3M	127.9M	78.5M
Other Operating Expenses i	-	-	-	-	-
Total Operating Expenses i	284.4M	252.9M	240.5M	190.2M	122.4M
Operating Income i	230.1M	171.8M	125.1M	113.5M	53.3M
Operating Margin % i	40.3%	36.1%	29.9%	33.0%	25.8%
Non-Operating Items
Interest Income i	35.9M	21.7M	9.3M	2.1M	301.0K
Interest Expense i	-	-	-	-	-
Other Non-Operating Income	-2.4M	-8.3M	-1.2M	-1.7M	4.2M
Pre-tax Income i	263.6M	185.2M	133.2M	114.0M	57.8M
Income Tax i	40.4M	37.6M	20.3M	-40.8M	7.6M
Effective Tax Rate % i	15.3%	20.3%	15.3%	-35.8%	13.1%
Net Income i	223.2M	147.6M	112.8M	154.8M	50.2M
Net Margin % i	39.1%	31.0%	26.9%	45.1%	24.3%
Key Metrics
EBITDA i	242.9M	190.4M	136.5M	119.8M	52.3M
EPS (Basic) i	$1.19	$0.78	$0.58	$0.82	$0.12
EPS (Diluted) i	$1.11	$0.72	$0.53	$0.70	$0.12
Basic Shares Outstanding i	186841000	190172000	193176000	163484000	178207520
Diluted Shares Outstanding i	186841000	190172000	193176000	163484000	178207520

Income Statement Trend

Doximity Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets
Cash & Equivalents i	209.6M	96.8M	158.0M	112.8M	66.4M
Short-term Investments i	706.0M	666.1M	683.0M	685.3M	76.1M
Accounts Receivable i	128.4M	101.3M	107.0M	81.1M	50.3M
Inventory i	-	-	-	-	-
Other Current Assets	44.6M	48.7M	27.4M	19.4M	10.7M
Total Current Assets i	1.1B	912.9M	975.5M	904.1M	209.4M
Non-Current Assets
Property, Plant & Equipment i	8.9M	12.3M	13.8M	1.1M	1.3M
Goodwill i	159.0M	163.2M	167.7M	45.7M	47.4M
Intangible Assets i	23.1M	27.3M	31.8M	7.9M	9.6M
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	62.1M	46.5M	36.6M	50.8M	4.9M
Total Non-Current Assets i	175.7M	166.4M	161.4M	87.2M	42.3M
Total Assets i	1.3B	1.1B	1.1B	991.4M	251.7M
Liabilities
Current Liabilities
Accounts Payable i	1.4M	2.3M	1.3M	463.0K	1.5M
Short-term Debt i	2.2M	2.1M	1.8M	642.0K	970.0K
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	11.5M	14.3M	11.3M	4.3M	3.5M
Total Current Liabilities i	156.3M	147.2M	139.5M	111.3M	102.0M
Non-Current Liabilities
Long-term Debt i	10.2M	12.4M	13.9M	447.0K	284.0K
Deferred Tax Liabilities i	-	-	-	-	-
Other Non-Current Liabilities	15.0M	18.1M	17.2M	956.0K	972.0K
Total Non-Current Liabilities i	25.4M	30.7M	31.3M	1.5M	82.9M
Total Liabilities i	181.7M	178.0M	170.8M	112.8M	185.0M
Equity
Common Stock i	189.0K	187.0K	194.0K	192.0K	83.0K
Retained Earnings i	186.9M	80.0M	217.9M	191.1M	36.3M
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	1.1B	901.4M	966.1M	878.6M	66.7M
Key Metrics
Total Debt i	12.4M	14.5M	15.6M	1.1M	1.3M
Working Capital i	932.4M	765.7M	835.9M	792.9M	107.4M

Balance Sheet Composition

Doximity Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income i	223.2M	147.6M	112.8M	154.8M	50.2M
Depreciation & Amortization i	10.7M	10.3M	10.3M	5.0M	3.7M
Stock-Based Compensation i	72.4M	51.1M	47.8M	31.4M	7.3M
Working Capital Changes i	-26.9M	-4.0M	-17.6M	-31.2M	12.9M
Operating Cash Flow i	279.9M	209.4M	178.8M	130.1M	88.8M
Investing Activities
Capital Expenditures i	0	-147.0K	-1.7M	-1.9M	-245.0K
Acquisitions i	0	0	-53.5M	0	-27.5M
Investment Purchases i	-675.6M	-472.9M	-190.6M	-1.3B	-78.9M
Investment Sales i	652.8M	509.9M	190.3M	681.7M	40.5M
Investing Cash Flow i	-22.8M	36.8M	-55.4M	-636.8M	-66.1M
Financing Activities
Share Repurchases i	-120.3M	-280.7M	-85.3M	-2.7M	-2.0M
Dividends Paid i	-	-	-	-	-
Debt Issuance i	-	-	-	-	-
Debt Repayment i	-	-	-	-	-
Financing Cash Flow i	-154.4M	-292.9M	-89.1M	546.4M	-3.5M
Free Cash Flow i	266.7M	178.3M	173.4M	120.9M	78.4M
Net Change in Cash i	102.6M	-46.6M	34.3M	39.7M	19.3M

Cash Flow Trend

Doximity Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 52.84

Forward P/E 51.95

Price to Book 11.30

Price to Sales 19.64

PEG Ratio 51.95

Profitability Ratios

Profit Margin 39.88%

Operating Margin 37.48%

Return on Equity 24.25%

Return on Assets 13.13%

Financial Health

Current Ratio 6.47

Debt to Equity 1.16

Beta 1.36

Per Share Data

EPS (TTM) $1.17

Book Value per Share $5.47

Revenue per Share $3.15

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
docs	11.6B	52.84	11.30	24.25%	39.88%	1.16
Veeva Systems	45.6B	59.15	7.33	14.06%	27.34%	1.24
Ge Healthcare	34.0B	15.25	3.50	25.80%	11.22%	107.67
Tempus AI	12.4B	33.14	39.94	-97.95%	-20.98%	275.63
HealthEquity	7.7B	65.16	3.64	5.77%	9.80%	52.11
Waystar Holding	6.2B	64.55	1.95	2.81%	8.50%	39.60

Financial data is updated regularly. All figures are in the company's reporting currency.